Biology

Brain Circuit Changes Explain Why Parkinson’s Drug Causes Involuntary Movements

How the science connects

NeuroplasticityParkinson's diseaseDopamine

AI Insight

This study investigated brain structural changes associated with L-DOPA induced dyskinesia (LID), involuntary movements that develop in Parkinson's disease patients undergoing long-term dopamine replacement therapy. Using advanced brain imaging techniques in a rat model of Parkinson's disease, researchers found that LID severity correlated with microstructural alterations not only in the expected nigrostriatal dopamine system but across widespread brain networks including the cerebellum and prefrontal cortex. The findings suggest that LID results from systemic dysfunction across multiple brain circuits rather than localized changes in the dopamine system alone.


Understanding the brain-wide neural circuit changes underlying LID could lead to more targeted therapeutic interventions to prevent or reduce these debilitating side effects in Parkinson's patients receiving L-DOPA treatment. The identification of specific brain regions beyond the dopamine system opens new potential targets for treatment development.


⚠️ Preprint – Noch nicht peer-reviewed

Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.

Dopaminergic replacement therapy via L-DOPA is the major medical therapy for Parkinsons Disease. Long-term L-DOPA administration is known to cause dyskinetic movements, L-DOPA Induced Dyskinesia (LID). It remains unclear if the LID related, maladaptive changes in brain structure/function are localized to neural circuits within the nigrostriatal DA system or have brainwide impact. We employed multi-shell diffusion magnetic resonance imaging and correlational tractography to investigate structural brain networks associated with daily administration of L-DOPA and the development of LID in the unilateral 6-hydroxydopamine rat model. 53% of rats receiving L-DOPA therapy developed severe LID. Tractography found brainwide statistical maps positively and negatively associated with LID severity highlighted by bilateral neural circuits contained in the lesioned nigrostriatal system as well as others including the cerebellum and prefrontal cortex. These results suggest that systemic dysfuntion in brainwide neural circuits forms the mechanistic basis the maladaptive changes underlying LID.

Source: Levodopa induced dyskinesia severity is linked to distinct microstructural alterations in nigrostriatal and brainwide neural circuits